These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of CB1 receptors in psychostimulant addiction. Wiskerke J; Pattij T; Schoffelmeer AN; De Vries TJ Addict Biol; 2008 Jun; 13(2):225-38. PubMed ID: 18482432 [TBL] [Abstract][Full Text] [Related]
4. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Müller CP; Carey RJ; Huston JP; De Souza Silva MA Prog Neurobiol; 2007 Feb; 81(3):133-78. PubMed ID: 17316955 [TBL] [Abstract][Full Text] [Related]
5. The role of serotonin in drug use and addiction. Müller CP; Homberg JR Behav Brain Res; 2015 Jan; 277():146-92. PubMed ID: 24769172 [TBL] [Abstract][Full Text] [Related]
6. [Structural plasticity associated with drugs addiction]. Zhu J; Cao GF; Dang YH; Chen T Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):413-8. PubMed ID: 22363978 [TBL] [Abstract][Full Text] [Related]
7. Effects of withdrawal from repeated amphetamine exposure in peri-puberty on neuroplasticity-related genes in mice. Calabrese F; Richetto J; Racagni G; Feldon J; Meyer U; Riva MA Neuroscience; 2013 Oct; 250():222-31. PubMed ID: 23872394 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of psychostimulant-induced structural plasticity. Golden SA; Russo SJ Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 22935995 [TBL] [Abstract][Full Text] [Related]
9. Amphetamine- and nicotine-induced cross-sensitization in adolescent rats persists until adulthood. Santos GC; Marin MT; Cruz FC; Delucia R; Planeta CS Addict Biol; 2009 Jul; 14(3):270-5. PubMed ID: 19523043 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced neurobehavioral plasticity: the role of environmental context. Badiani A; Robinson TE Behav Pharmacol; 2004 Sep; 15(5-6):327-39. PubMed ID: 15343056 [TBL] [Abstract][Full Text] [Related]
11. MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity. Schenk S Neurosci Biobehav Rev; 2011 Apr; 35(5):1203-18. PubMed ID: 21184779 [TBL] [Abstract][Full Text] [Related]
13. New perspectives on using brain imaging to study CNS stimulants. Lukas SE Neuropharmacology; 2014 Dec; 87():104-14. PubMed ID: 25080072 [TBL] [Abstract][Full Text] [Related]
14. Designer psychostimulants: pharmacology and differences. Iversen L; White M; Treble R Neuropharmacology; 2014 Dec; 87():59-65. PubMed ID: 24456744 [TBL] [Abstract][Full Text] [Related]
15. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Pierce RC; Bari AA Rev Neurosci; 2001; 12(2):95-110. PubMed ID: 11392459 [TBL] [Abstract][Full Text] [Related]
16. Psychomotor stimulants and neuronal plasticity. Wolf ME; Sun X; Mangiavacchi S; Chao SZ Neuropharmacology; 2004; 47 Suppl 1():61-79. PubMed ID: 15464126 [TBL] [Abstract][Full Text] [Related]
17. From vice to virtue: insights from sensitization in the nonhuman primate. Castner SA; Williams GV Prog Neuropsychopharmacol Biol Psychiatry; 2007 Nov; 31(8):1572-92. PubMed ID: 17904719 [TBL] [Abstract][Full Text] [Related]
18. [Is there solid evidence for reorganization of the neural network associated with development of behavioral sensitization to psychostimulants?]. Ujike H; Kodama M Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):47-52. PubMed ID: 10464775 [TBL] [Abstract][Full Text] [Related]
19. Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology. Eisch AJ; Harburg GC Hippocampus; 2006; 16(3):271-86. PubMed ID: 16411230 [TBL] [Abstract][Full Text] [Related]
20. Structural plasticity associated with exposure to drugs of abuse. Robinson TE; Kolb B Neuropharmacology; 2004; 47 Suppl 1():33-46. PubMed ID: 15464124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]